Related Experiment Videos
Transluminal atherectomy for occlusive peripheral vascular disease
J B Simpson1, M R Selmon, G C Robertson
1Sequoia Hospital, Redwood City, California.
The American Journal of Cardiology
|May 9, 1988
Summary
Transluminal atherectomy effectively removes atheroma from peripheral arteries, significantly reducing stenosis. Achieving less than 30% residual stenosis is crucial for preventing restenosis and improving long-term outcomes.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Medical Device Technology
Background:
- Occlusive peripheral vascular disease poses significant health risks.
- Atherectomy offers a minimally invasive approach to treat arterial stenosis.
Purpose of the Study:
- To evaluate the efficacy and safety of transluminal atherectomy for peripheral vascular disease.
- To analyze the histopathology of removed atheromatous specimens.
- To determine the impact of residual stenosis on restenosis rates.
Main Methods:
- Sixty-one patients with peripheral vascular disease underwent transluminal atherectomy using various catheter sizes.
- Atheromatous specimens were collected and analyzed histopathologically.
- Angiographic follow-up was conducted at six months to assess restenosis.
Main Results:
- Mean stenosis reduced from 71% to 23% after atherectomy.
- 87% of stenoses were reduced to less than 45%.
- Lower restenosis rates (18%) were observed in patients with <30% residual stenosis compared to those with >30% (52%).
Conclusions:
- Transluminal atherectomy is an effective and safe method for removing atheromatous deposits.
- Complete atherectomy, achieving <30% residual stenosis, is vital for reducing long-term restenosis.
- Histopathologic differences were noted between original and restenotic lesions.